MEI Pharma, Inc. (MEIP) Forms $2.16 Double Bottom; SHIN-ETSU CHEMICAL CO LTD ORDINARY SHARE (SHECF) Shorts Lowered By 7.05%

MEI Pharma, Inc. (MEIP) formed double bottom with $2.03 target or 6.00% below today’s $2.16 share price. MEI Pharma, Inc. (MEIP) has $80.03 million valuation. The stock increased 6.93% or $0.14 during the last trading session, reaching $2.16. About 122,596 shares traded or 43.53% up from the average. MEI Pharma, Inc. (NASDAQ:MEIP) has risen 32.91% since April 30, 2017 and is uptrending. It has outperformed by 21.36% the S&P500.

SHIN-ETSU CHEMICAL CO LTD ORDINARY SHARE (OTCMKTS:SHECF) had a decrease of 7.05% in short interest. SHECF’s SI was 138,400 shares in April as released by FINRA. Its down 7.05% from 148,900 shares previously. With 300 avg volume, 461 days are for SHIN-ETSU CHEMICAL CO LTD ORDINARY SHARE (OTCMKTS:SHECF)’s short sellers to cover SHECF’s short positions. The SI to SHIN-ETSU CHEMICAL CO LTD ORDINARY SHARE’s float is 0.03%. The stock increased 5.93% or $5.99 during the last trading session, reaching $106.95. About shares traded. Shin-Etsu Chemical Co., Ltd. (OTCMKTS:SHECF) has 0.00% since April 30, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 4 analysts covering MEI Pharma (NASDAQ:MEIP), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. MEI Pharma has $7 highest and $2.5 lowest target. $5.33’s average target is 146.76% above currents $2.16 stock price. MEI Pharma had 8 analyst reports since September 4, 2015 according to SRatingsIntel. The stock has “Buy” rating by Oppenheimer on Wednesday, August 2. On Monday, June 26 the stock rating was maintained by Oppenheimer with “Buy”. Oppenheimer maintained MEI Pharma, Inc. (NASDAQ:MEIP) rating on Wednesday, June 14. Oppenheimer has “Buy” rating and $6.5000 target. The company was maintained on Wednesday, May 31 by Oppenheimer. The rating was maintained by Wedbush on Friday, September 4 with “Hold”. The stock has “Hold” rating by Stifel Nicolaus on Wednesday, September 6.

Analysts await MEI Pharma, Inc. (NASDAQ:MEIP) to report earnings on May, 3. They expect $-0.27 earnings per share, down 1,250.00% or $0.25 from last year’s $-0.02 per share. After $-0.16 actual earnings per share reported by MEI Pharma, Inc. for the previous quarter, Wall Street now forecasts 68.75% negative EPS growth.

Shin-Etsu Chemical Co., Ltd. manufactures and sells polyvinyl chloride , semiconductor silicon wafers, silicones, and rare earth magnets worldwide. The company has market cap of $43.04 billion. It offers PVC for use in window profiles, plastic greenhouses, siding materials, and electric lines coating materials, as well as PVC pipes and conduits; caustic soda for use in paper and pulp, soap and detergents, waste water treatment, and alumina; methanol; and chloromethane. It has a 22.79 P/E ratio. The firm also provides semiconductor silicon wafers that are used as substrate materials in personal computers, smartphones, and televisions, as well as automobiles; and compound semiconductor products for use in outdoor displays, traffic lights, in-vehicle stop lamps, sensor light sources, etc.

MEI Pharma, Inc. (NASDAQ:MEIP) Institutional Positions Chart